Marketing & Strategy
The evolution of HCP engagement – COVID-19 recovery phase
Please log in to Health Industry Hub to view this content in Marketing & Strategy sub-menu.
Human Resources
PAIG co-chairs reflect on industry progress in D&I with sights set on next phase goals
Human Resources: In this Health Industry Hub podcast, Medicines Australia’s PAIG (Pharma Australia Inclusion Group) co-chairs reflect on their contribution […]
MoreNews & Trends - Medical Technology
Stryker announces fellowships for medtech partner projects
MedTech News: Stryker announced two of its partner research projects have secured fellowship funding from the Australian government’s Researcher Exchange […]
MoreNews & Trends - Pharmaceuticals
New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients
Pharma News: Update to international guidelines recommend two new drugs for the treatment of COVID-19. Eli Lilly’s oral JAK inhibitor, […]
MoreNews & Trends - Pharmaceuticals
Novartis shifts focus as CAR T-cell therapy fails to add benefit in non-Hodgkin lymphoma
Pharma News: Novartis’ chimeric antigen receptor (CAR) T-cell therapy was not found to improve event-free survival over what was seen […]
More